MSD pharma likely to participate when govt floats tender for vaccine against cervical cancer

The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, was launched last month. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), wrote a letter to the Health Ministry recently, saying its first indigenous HPV vaccine will be available in the private market at an MRP of Rs 2,000 per dose, it has been learnt. CERVAVAC will be available in two-dose glass vial presentation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/v8WzjyP
via IFTTT